2-meOE 2 is also a potent inhibitor of angiogenesis in tumor tissues
#HealthcareInnovation #ObesityCare #ChronicDisease #Pharma #GLP1 #PublicHealth #IndiaHealthcare #HealthEquity #LifeSciences #FutureOfMedicine News source credits: LIVEMINT ( To view or add a comment, sign in 270 followers
It is used to manage alcoholic fatty liver (disease that occurs due to heavy alcohol use), liver fibrosis/cirrhosis (scarring of liver due to excessive consumption of alcohol), and hepatitis (inflammation of liver) in affected individuals
However, those with significantly restricted intake, persistent gastrointestinal symptoms, or pre-existing nutritional concerns may benefit from targeted assessment
Founder of the Better Nutrition Program and RDN Ashley Koff shared, We can use awareness of GLP-1 medications to introduce the public to weight-health hormones and how they regulate numerous functions in the body known collectively as weight health. In doing this, dietitians can expand the reach of GLP-1, GIP beyond medications and help people learn to assess and as indicated, optimize their own hormones whether they ever use a medication or not. Rethinking food and health communications As GLP-1s continue to change daily routines and expectations, helping consumers make the right decisions to stay healthy but also being present with family and friends at meals and other food-based activities will test how we communicate about food and health